NYULMC CareSmarts Pilot
Status: | Completed |
---|---|
Conditions: | Diabetes, Diabetes |
Therapuetic Areas: | Endocrinology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 5/6/2017 |
Start Date: | March 1, 2016 |
End Date: | May 2, 2017 |
NYULMC-CareSmarts Study: A Pilot Study to Determine the Feasibility, Acceptability, and Potential Efficacy of an SMS-based Mobile Intervention to Enhance Type 2 Diabetes Self-management
CareSmarts is a theory-driven behavioral intervention designed to improve self-care among
patients with Type 2 diabetes (T2D) with poor glycemic control (HbA1c>8%), through multiple
mediators, including cuing, education, self-efficacy, social support, and health beliefs.
Individuals will be randomly assigned with equal allocation to either the CareSmarts
intervention or to usual care for 6 months.
patients with Type 2 diabetes (T2D) with poor glycemic control (HbA1c>8%), through multiple
mediators, including cuing, education, self-efficacy, social support, and health beliefs.
Individuals will be randomly assigned with equal allocation to either the CareSmarts
intervention or to usual care for 6 months.
CareSmarts is a mobile diabetes program that provides self-management support and team-based
care management for people with diabetes through automated SMS messages. The program is a
theory-driven behavioral intervention designed to improve self-care through multiple
mediators, including cuing, education, self-efficacy, social support, and health beliefs.
Participants in the program receive educational and motivational text messages about
diabetes self-care, some prompts to engage in a particular action (for example, "Time to
check your blood sugar"), and some self-assessment questions (such as, "Do you need refills
of any of your medications?") to which the patient responds by texting. Participants'
responses to self-assessment questions are used to facilitate remote monitoring and care
management by the health care team. A response that is outside established parameters
triggers an alert. Using protocols, nurses respond to each alert by the next business day.
care management for people with diabetes through automated SMS messages. The program is a
theory-driven behavioral intervention designed to improve self-care through multiple
mediators, including cuing, education, self-efficacy, social support, and health beliefs.
Participants in the program receive educational and motivational text messages about
diabetes self-care, some prompts to engage in a particular action (for example, "Time to
check your blood sugar"), and some self-assessment questions (such as, "Do you need refills
of any of your medications?") to which the patient responds by texting. Participants'
responses to self-assessment questions are used to facilitate remote monitoring and care
management by the health care team. A response that is outside established parameters
triggers an alert. Using protocols, nurses respond to each alert by the next business day.
Inclusion Criteria:
- have a DRG Code of T2D, and be prescribed at least one oral T2D drug and/or insulin.
- must own an SMS capable mobile device and be willing to send and receive SMS messages
regarding T2D self-management.
- The participant's physician of record will have verified that his/her patient can
safely participant in an intervention study that targets an HbA1c <7%.
Exclusion Criteria:
- unable or unwilling to provide informed consent
- unable to participate meaningfully in an intervention that involves use of SMS
messages (e.g., due to uncorrected sight impairment, illiterate,
non-English-speaking)
- unwilling to accept randomization assignment
- pregnant, plans to become pregnant in the next 6 months, or who become pregnant
during the study
- gestational diabetes
- breastfeedling
- individuals who are institutionalized (e.g., in a nursing home or personal care
facility, or those who are incarcerated and have limited control over
self-management)
We found this trial at
1
site
550 1st Ave
New York, New York 10016
New York, New York 10016
(212) 263-7300

Principal Investigator: Mary Sevick, MD
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials
